title: Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want?
abstract: OBJECTIVE
  To assess methadone maintenance treatment (MMT) patients' willingness to use, and perceived efficacy of, conventional and unconventional group stress reduction treatments.
  
  
  METHODS
  A survey, developed by the authors, was administered to 150 MMT patients.
  
  
  RESULTS
  Levels of treatment willingness and perceived efficacy for both conventional and unconventional treatments were relatively high; however, ratings for conventional interventions were, on average, significantly higher than those for unconventional ones. The highest rated conventional and unconventional treatments in terms of willingness and perceived efficacy were nutrition and spiritual counseling, respectively, whereas the lowest rated conventional and unconventional group treatments were anger management and visualization training, respectively. White race was a significant predictor of lower willingness to try conventional and unconventional group therapies and lower perceived efficacy of unconventional group treatment, whereas female sex and older age were significant predictors of higher levels of willingness to try unconventional group treatment. Higher levels of substance use problems were associated with increased willingness to try conventional group treatment. Higher levels of anxiety emerged as a significant independent predictor of treatment willingness and perceived efficacy for both conventional and unconventional group treatments.
  
  
  CONCLUSIONS
  The relatively high levels of treatment willingness and perceived efficacy of conventional and unconventional group stress reduction treatments point to the feasibility of offering these interventions in MMT and suggest that, in particular, high levels of anxiety are associated with greater treatment willingness and perceived treatment efficacy.
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. declan.barry@yale.edu
authors.forename: Declan T
authors.initials: DT
authors.lastname: Barry
authors.forename: Mark
authors.initials: M
authors.lastname: Beitel
authors.forename: Timothy
authors.initials: T
authors.lastname: Breuer
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Cutter
authors.forename: Jonathan
authors.initials: J
authors.lastname: Savant
authors.forename: Skye
authors.initials: S
authors.lastname: Peters
authors.forename: Richard S
authors.initials: RS
authors.lastname: Schottenfeld
authors.forename: Bruce J
authors.initials: BJ
authors.lastname: Rounsaville
mesh_terms: D000328:Adult; D017677:Age Distribution; D000529:Complementary Therapies / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000379:methods; D009293:Opioid-Related Disorders / Q000150:complications / Q000188:drug therapy*; D010349:Patient Compliance / Q000706:statistics & numerical data; D057240:Patient Preference / Q000706:statistics & numerical data; D011615:Psychotherapy, Group / Q000379:methods*; D044469:Racial Groups / Q000706:statistics & numerical data; D017678:Sex Distribution; D013315:Stress, Psychological / Q000150:complications / Q000628:therapy*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D009294:Narcotics; D008691:Methadone